Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Other financing activities (2024)

Zentalis Pharmaceuticals (ZNTL) has 1 years of Other financing activities data on record, last reported at $241000.0 in Q1 2024.

  • For Q1 2024, Other financing activities changed N/A year-over-year to $241000.0; the TTM value through Sep 2024 reached $241000.0, changed N/A, while the annual FY2020 figure was $18.4 million, N/A changed from the prior year.
  • Other financing activities reached $241000.0 in Q1 2024 per ZNTL's latest filing.
  • Across five years, Other financing activities topped out at $241000.0 in Q1 2024 and bottomed at $241000.0 in Q1 2024.